AIm: Deep venous thrombosis (DVT) and pulmonary embolism (PE) are the most frequent surgical problems and associated with high morbidity and mortality. Neurosurgical patients constitute a unique group where prophylaxis with anticoagulant and antiaggregant agents are relatively contraindicated due to the natural course of vascular problems such as aneurysms, hemorrhagic tumors or hematomas or increased vulnerability to complex spinal surgeries and trauma. mAterIAl and methOds: We included 67 patients predicted to be immobilized for 2 or more months in this retrospective analysis. A vena cava filter was inserted between the first and seventh postoperative day in 40 patients in a prophylactic manner whereas 27 patients received low dose heparin for the same purpose. The patients were evaluated for symptomatic DVT or PE.
INTRODUCTION
Deep venous thrombosis (DVT) and pulmonary embolism (PE) are frequently encountered in surgical patients and associated with high morbidity and mortality during hospitalization. Patients with neurosurgical problems constitute a unique group since these patients need strict control of hemorrhage risk in the perioperative period. Complex spinal surgeries for patients with severe neurological deficits may be associated with long-term immobilization and some brain tumors are associated with hypercoagulability. Hamilton et al stated that incidence of DVT in a high risk group of neurosurgical patients was 18-50% while that of PE was 0-25% (13) . Moreover, neurosurgical patients presenting with cerebral aneurysm, arteriovenous malformation, hemorrhagic tumor and trauma form the most challenging group and are at higher risk. Given the possibility of a surgical intervention, it is questionable to use an antiaggregant and anticoagulant agent for DVT and PE prophylaxis due to high risk of bleeding. Pharmacological agents might result in catastrophic complications in the peri-and postoperative period and their use is therefore not considered to be beneficial (1, 6, 7, 23, 18, 19) . Although absolute and relative indications of vena cava filters are still debatable, their prophylactic use in patients with neurosurgical problems has not been reported thoroughly in the literature (8, 10, 20, 22, 24, 26, 28) .
Conventional practice includes use of elastic bandage, surgical stockings or intermittent pneumatic compression. Pharmacological prophylaxis with lowered dose low molecular weight heparin is reported to be a safer alternative but the use of these agents might also be hazardous (1, 6, 7, 23) . Vena cava filters (VCF) offer an alternative-adjuvant treatment option for prevention of the pulmonary embolism in high risk patient groups where pharmacological prophylaxis is risky or contraindicated (1, 4, 26) . The PREPIC study showed that VCF is effective in preventing PE (26). Current indications of VCF include patients with acute VTE or DVT who cannot receive anticoagulation or in whom adequate anticoagulation has clearly failed to prevent recurrent VTE.
In a clinical setting, two thirds of placed VCF were reported to be permanent filters instead of retrievable filters (32) . Retrievable inferior vena cava filters (IVCFs) were designed to provide temporary protection from pulmonary embolism in high-risk situations and short-term surgeries. Several reports pointed to their questionable influence in protection of VTE and danger of permanently implanted filters that lead to potential complications. Severe complications, some of which can be fatal, have been reported with IVC filters: filter strut fracture, filter migration/embolization, IVC or aortic penetration, and thrombotic complications (5, 33) . The incidence of these complications varies depending on the series. Nevertheless, the use of IVC filters has been increasing even in the setting of prophylactic use without evidence of PE or DVT (30, 31) . VCF has no effect on thrombus formation or lysis of the existing thrombus. VCF prevents PE by trapping the thrombus and preventing its migration to the pulmonary vasculature.
In the present study, we present our experience on vena cava filters in the prevention of PE compared to subcutaneous low molecular weight heparin in a group of patients with neurosurgical problems.
MATERIAL and METHODS
A total of 67 patients who underwent spinal surgery and craniotomy due to intracranial tumor or tumor-like masses were included in the study. In this retrospective study, the patients were considered to have a high risk for thromboembolism due to prolonged immobilization in the postoperative period and a debilitated status. Patients with a history of documented DVT or PE were excluded. Patients operated at the Neurosurgery Clinics of Ankara Numune Education and Research hospital between March 2010 and March 2013 were analyzed. Patients predicted to be immobilized for at least 2 or more months in accordance with the postoperative clinical status (severe postoperative deficits) were included. There were 32 male and 35 female patients. The mean age of the patients was 51.8 (range 23 to 82) years. All patients used an elastic bandage or surgical stockings at the perioperative period. The mean duration of hospital stay after implantation was 4.3 days.
The Vena-Tech TM LP vena cava filter (B. Braun Interventional Systems Med. Inc., PA. USA) was the only preferred type for insertion. Vena cava filters were placed at Interventional Radiology clinics of Ankara Numune Education and Research Hospital by two interventional radiologists. All patients were operated by the same neurosurgeon. On the other hand, patients who received low molecular weight heparin were operated by another neurosurgeon. The vena cava filter was inserted between the first and seventh postoperative day in 40 patients in a prophylactic manner before discharge whereas 27 patients received low dose heparin for the same purpose (Table I, II) .
On clinical follow-up, lower extremity Doppler ultrasonography and pulmonary CT angiography were performed for cases with suspected DVT and PE. Patients in the filter group were followed up for 22 months on average after discharge for complications regarding DVT, PE and status of VCF. Patients in the heparin group were followed up for 16 months on average and evaluated for symptomatic DVT or PE.
RESULTS
All filters were inserted percutaneously under ultrasound and fluoroscopy guidance. The right femoral route was selected in all patients and filters were placed into IVC inferior to the renal vein origin successfully in all patients. There was no periprocedural complication.
Seven patients in filter group died due to heart failure, sepsis, and intracranial hemorrhage during hospitalization but no death or surgical site hemorrhages were recorded in subcutaneous heparin group. Since there was no randomization, an inevitable tendency towards VCF use was present in patients with major systemic problems.
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Furthermore there is no statistical age difference between two groups with a p value of 0.714 (mean age of 55.6 versus 46.2 years), which is insignificant.
DVT occurred in one patient and was confirmed by ultrasonography during hospitalization. PE was not observed in any of the patients from either group. Patients were followed up for 22 months on average after discharge. Two more patients in the filter group died during the follow-up period due to underlying malignancy. One patient was diagnosed with a developed DVT at the first month of follow-up. No PE was reported in patients of filter group on follow-up.
In the heparin group one patient was diagnosed with DVT during hospitalization and again there was no PE. Patients were followed for 16 months on average after discharge. No symptomatic DVT or PE was observed during follow-up.
DISCUSSION
Venous thromboembolism is a frequently encountered complication in neurosurgical patients and associated with high morbidity and mortality. In the present study, patients with brain tumors and spinal disorders who were immobilized due to postoperative severe deficits for more than 2 predicted months were included.
Benign or malignant brain tumors, spinal cord injury, head trauma, stroke, prolonged surgery or immobilization are well known risk factors for developing DVT and PE (17) . It is also well known that long postoperative immobilization period after surgery is considered to be risky for DVT. Patients with gliomas are considered to be in the high risk group since gliomas secrete several tissue factors that activate coagulation cascades. In addition, tissue damage to the brain as a consequence of craniotomy, chemotherapy or radiotherapy results in hypercoagulability (29) . In a retrospective study by Khaldi et al. on patients hospitalized in the Intensive Care Unit (ICU), the incidence of DVT was reported to be 84% within one week in a separate group of high risk neurosurgical ICU patients and an additional 8% within two weeks in high risk patients with neurosurgical pathologies (17) . Since DVT is strongly associated with PE, these patients are also at risk of PE. PE rates reported in the literature differ from 1.5% to 5% with a mortality rate of 9% to 50% (2) . In the present study there was a slight tendency to use VCF as a prophylactic measure in high risk neurosurgical patients with associated systemic problems.
An increased preference to use filters more in patients with severe systemic problems might have resulted in increased mortality of VCF group. Marked predisposition to use VCF in high risk neurosurgical patients resulted in increased mortality in the filter group but this does not signify that these deaths were due to VCF, neurological sequelae or related complications. This predisposition was probably caused by the awareness of the surgeon about the risks of a permanent filter (25) (26) (27) .
Several studies have focused on PE and DVT due to its preventable nature. Mechanical methods such as compression stockings, intermittent compression devices and early mobilization are widely used and reported to reduce the incidence of DVT and PE (6, 11, 21) . Mechanical prophylaxis assisted by the use of heparin or low-molecular weight heparin further reduces the incidence of these conditions. However, pharmacological prophylaxis may cause 
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cava filters were implanted for prophylactic purposes and filters were noted to decrease PE significantly compared to control group (22) . In the same study VCF indications were limited to hypercoagulability, prolonged immobilization, staged procedures of longer than 5 segment levels, combined anterior-posterior approaches, iliocaval manipulation during exposure, and anesthetic time of more than 8 hours excluding the patients with a history of DVT or PE. Ozturk et al reported a significant decrease in PE risk in their study on 129 patients with similar characteristics (24) . In the literature, there are case series, performed on a lower number of patients, pointing to the use of vena cava filters in patients subjected to complex spinal surgery as a safe and effective method in preventing PE (8, 20, 28) . In the present study, pulmonary embolism was not reported in both groups. Although total number of patients in this study is relatively insufficient to make a general conclusion, it might be concluded that VCFs do not provide further protection compared to primary prophylaxis with subcutaneous heparin.
Studies on prophylactic use of vena cava filters among neurosurgical patients excluding spinal surgery group are rather limited. In their retrospective study, Ghanim et al compared the effects of anticoagulation and VCF on hospital and overall mortality rate in 175 patients with intracranial malignancy and intracranial hemorrhage. The data obtained in this study was not considered to be statistically significant although it was determined that VCF had a reduction of 64% in hospital and 28% on overall mortality (10). In our study there is a slight favor towards low molecular weight heparin compared to filter usage that points to high efficiency of low molecular weight heparin.
The major limitations of the present study are the limited number of patients and heterogeneous patient population. All patients received mechanical prophylaxis and number of patients in each group is not equal. Two patients in filter group developed DVT during hospitalization or on follow-up and one patient from low molecular weight heparin group developed DVT on follow-up. As none of the patients in both groups developed PE during hospitalization and on followup statistically comparison of VCF and heparin efficacy in preventing PE is not applicable.
It is difficult to advocate the prophylactic indication of VCF for routine clinical practice due to limited number of studies and absence of randomized clinical trials. Though it appears an effective method of prophylaxis in selected patients, VCF should be cautiously used for routine prophylactic manner when findings of this study are considered.
hemorrhagic complications that might result in catastrophic outcomes. There seems to be a lack of consensus on the use of pharmacological prophylaxis. Some authors suggest pharmacological prophylaxis to be safe (12, 17) while there are reports that indicate the risk of hemorrhage is higher (1, 6, 7, 14) .
Vena cava implantation has been the preferred method of prophylaxis for VTE in the last decades. Ease of implantation and elimination of the need for anticoagulation at the postoperative risky period have increased usage by physicians. However, vena cava implantation may be associated with complications during implantation despite image guidance or due to the filter itself on follow-up. The incidence of complications is lower with the new generation of vena cava filters with their low profile and ease of application. However, complications such as filter migration, vena cava perforation, and vena cava thrombosis are still reported. The incidence of complications is reported to be 0-69% in the literature (25) (26) (27) .
In the present study, all filters were inserted on a permanent basis. Retrieval of filters is also reported to be associated with a high risk of complications. It was considered that a late attempt to remove filters from the patients might lead to further complications since patients included in the study had severe neurological deficits.
It is reported that filter complications are dependent upon the duration of the presence of the filter in the vascular system and that the complications will be reduced after the removal of the filter following the DVT-PE risk period. In the present study, all filters seemed to be well tolerated by the patients on follow-up compared to the literature, which might be due to lack of DVT and PE at the time of insertion. Retrievable filters provide the interventionist a further option for removal but all filters were of the permanent type in the present study due to predicted long term neurological deficits. There is an increased tendency to use optional filters in recent years since they may be removed percutaneously within the period specified by the manufacturer. Retrieval of IVC filters might be complicated in patients with longer filter indwelling times (9) , and IVC penetration of filter struts may prevent successful retrieval 2 weeks after implantation (3). It should be noted that removal might be unsuccessful due to technical problems or the presence of thrombus on the filter itself.
The prophylactic use of vena cava filters for prevention of PE is still challenging. American College of Chest Physicians advocate the use of vena cava filters in cases with proven DVT and anticoagulation contraindicated or unsuccessful, however Society of Interventional Radiology points to prophylactic use for patients with high risk DVT and PE in addition to the above indications (15, 16) . There is not any randomized controlled study in the literature concerning the prophylactic use of vena cava filters in neurosurgical pathologies. 
